Literature DB >> 26674516

Serum Basal Paraoxonase 1 Activity as an Additional Liver Function Test for the Evaluation of Patients with Chronic Hepatitis.

Anand K Pyati1, Chandrakanth K Halappa2, Sudharani A Pyati3, Vinod Wali4.   

Abstract

BACKGROUND: The diagnostic accuracy of currently available standard panel of liver function tests is not satisfactory for the reliable diagnosis of chronic liver disorders. Earlier studies have reported that serum basal paraoxonase 1 (PON1) activity measurement may add a significant contribution to the liver function tests. AIM: To assess whether the measurement of serum basal paraoxonase 1 (PON1) activity would be useful as an index of liver function status in chronic hepatitis patients.
MATERIALS AND METHODS: The study included 50 chronic hepatitis patients and 50 apparently healthy controls based on inclusion & exclusion criteria. In all the subjects, standard liver function tests were analysed by using standard methods. Basal PON1 activity was estimated using spectrophotometric method by the hydrolysis of p-nitrophenylacetate. Student t-test, Pearson's correlation coefficient, diagnostic validity tests and ROC curve analysis were the methods used for the statistical analysis of the data.
RESULTS: The serum basal PON1 activity was significantly decreased in chronic hepatitis cases when compared to controls (p< 0.001). Also basal PON1 activity was positively correlated with serum total protein and albumin, and negatively correlated with serum total bilirubin, alanine amino transferase (ALT), and alkaline phosphatase (ALP) (p< 0.001) in chronic hepatitis cases but not in healthy controls. Diagnostic validity tests showed, basal PON1 activity was a better discriminator of chronic hepatitis than total protein, albumin and ALP with sensitivity of 68%, specificity of 100%, positive predictive value of 100% and negative predictive value of 75%. ROC curve analysis demonstrated highest diagnostic accuracy for ALT (AUC = 0.999) followed by PON1 (AUC = 0.990), total bilirubin (AUC = 0.977), ALP (AUC = 0.904), total protein (AUC = 0.790) and albumin (AUC = 0.595).
CONCLUSION: Diagnostic accuracy of serum PON1 activity is better than total bilirubin, total protein, albumin and ALP. PON1 activity measurement could significantly improve the current efficiency of a laboratory's evaluation of patients with suspected chronic hepatitis.

Entities:  

Keywords:  Alanine transaminase; Albumin; Alkaline phosphatase; Bilirubin; Chronic; Hepatitis; Human; PON1 protein

Year:  2015        PMID: 26674516      PMCID: PMC4668400          DOI: 10.7860/JCDR/2015/15917.6850

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  21 in total

1.  Serum arylesterase and paraoxonase activity in patients with chronic hepatitis.

Authors:  Suleyman Sirri Kilic; Suleyman Aydin; Nermin Kilic; Fazilet Erman; Suna Aydin; Ilhami Celik
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

2.  Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage.

Authors:  Natàlia Ferré; Jordi Camps; Eduard Prats; Elisabet Vilella; Antoni Paul; Lídia Figuera; Jorge Joven
Journal:  Clin Chem       Date:  2002-02       Impact factor: 8.327

3.  Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection.

Authors:  Natàlia Ferré; Judit Marsillach; Jordi Camps; Anna Rull; Blai Coll; Mònica Tous; Jorge Joven
Journal:  Clin Chim Acta       Date:  2005-11       Impact factor: 3.786

Review 4.  Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests.

Authors:  D R Dufour; J A Lott; F S Nolte; D R Gretch; R S Koff; L B Seeff
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

5.  Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration.

Authors:  T M Forte; M N Oda; L Knoff; B Frei; J Suh; J A Harmony; W D Stuart; E M Rubin; D S Ng
Journal:  J Lipid Res       Date:  1999-07       Impact factor: 5.922

Review 6.  HDL, its enzymes and its potential to influence lipid peroxidation.

Authors:  M I Mackness; P N Durrington
Journal:  Atherosclerosis       Date:  1995-06       Impact factor: 5.162

Review 7.  Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1.

Authors:  Sara P Deakin; Richard W James
Journal:  Clin Sci (Lond)       Date:  2004-11       Impact factor: 6.124

8.  Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis.

Authors:  M Aslan; M Horoz; Y Nazligul; C Bolukbas; F F Bolukbas; S Selek; N Aksoy; O Erel
Journal:  Int J Clin Pract       Date:  2008-09-20       Impact factor: 2.503

9.  Biochemical diagnosis of liver disease.

Authors:  P L Wolf
Journal:  Indian J Clin Biochem       Date:  1999-01

Review 10.  Studies on oxidative stress in liver diseases: important future trends in liver research.

Authors:  Kyuichi Tanikawa; Takuji Torimura
Journal:  Med Mol Morphol       Date:  2006-03       Impact factor: 2.070

View more
  1 in total

1.  Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease.

Authors:  Mircea Vasile Milaciu; Ștefan Cristian Vesa; Ioana Corina Bocșan; Lorena Ciumărnean; Dorel Sâmpelean; Vasile Negrean; Raluca Maria Pop; Daniela Maria Matei; Sergiu Pașca; Andreea Liana Răchișan; Anca Dana Buzoianu; Monica Acalovschi
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.